Compare ADMA Biologics Inc (ADMA) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance

ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.

The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.

TMF, the Direxion Daily 20+ Year Treasury Bull 3X ETF, trades at $34.62, down 0.46% on the day, with a bearish technical signal from moving averages. The fund provides 3x daily leveraged exposure to long-term U.S. Treasury bonds, making it highly sensitive to interest rate movements. Recent news highlights significant long-term value erosion, with a $10,000 investment five years ago now worth approximately $1,527, underscoring the risks of daily leverage reset in volatile markets.

The outlook for TMF hinges on the direction of long-term bond yields, with potential for sharp gains if rates fall but severe losses if they rise. It is suited only for short-term, high-risk traders due to leverage decay. Key risks include Federal Reserve policy shifts, inflation trends, and the structural drag of daily rebalancing, making it unsuitable for buy-and-hold investors.